Ligand · VHA
VHA · 22-methyl-13,18-dioxa-7-thia-3,5-diazatetracyclo[17.3.1.1~2,6~.1~8,12~]pentacosa-1(23),2(25),3,5,8(24),9,11,19,21-nonaen-4-amine
VHA, 22-methyl-13,18-dioxa-7-thia-3,5-diazatetracyclo[17.3.1.1~2,6~.1~8,12~]pentacosa-1(23),2(25),3,5,8(24),9,11,19,21-nonaen-4-amine (C21 H21 N3 O2 S, 379.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry).…
- Component
- VHA
- Formula
- C21 H21 N3 O2 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
VHA in 2 structures; the first of them:
- 3VHA · Hsp90 alpha N-terminal domain in complex with a macrocyclic inhibitor · VHA A237 · binds ASN51, SER52, ALA55, LYS58, ASP93, ILE96, GLY97, MET98 and 7 more
- 3VHA · HSP90 alpha N-terminal domain in complex with a macrocyclic inhibitor · VHA A237 · binds ASN51, SER52, ALA55, LYS58, ASP93, ILE96, GLY97, MET98 and 7 more
Residues it binds most
ASN 2, ASP 2, LYS 2, ALA 2, GLY 2, ILE 2, LEU 2, MET 2, PHE 2, SER 2 (residue and the binding sites it lines).
Found with
- MES · 2-(N-morpholino)-ethanesulfonic acid
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.